Trial Profile
Capecitabine/cyclophosphamide combination therapy for patients with advanced or metastatic breast cancer who have been previously treated with anthracyclines - a phase 2 study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cyclophosphamide (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 09 Apr 2011 Status changed from active, no longer recruiting to completed, according to University Hospital Medical Information Network - Japan.
- 04 Jun 2009 New trial record.